ByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boom
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-09-18 13:00 UTC+10:00
Section: Nutshell Therapeutics
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Asia, Technology & AI, China, Drugs, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
As AI’s role in drug design advances rapidly, Chinese start-ups are ramping up fundraising efforts
--------------------------------------------------------------------